Registration

Inauguration

Chairman's Welcome and Inaugural Talk

Renaissance in Pharmacognosy:The Need is Great and the Time is Now
Rathnam Chaguturu, CEO, Innovation Czar-iDDPartners

Memento Presentation

Coffee Break and Networking in Exhibition Area

Hall 1- Novel Heterocyclic Construction Using N-Heterocyclic Carbene Organocatalysis
Akkattu Biju, Senior Scientist, National Chemical Laboratory

Hall 2- A Novel Approach to Rescue the Neurodegenerative Diseases with the Modified Peptides Derived from Neuron Specific Kinase (Cdk5)
Harish Pant, Senior Investigator, National Institute of Health

Hall 1- DNA-Targeted Anticancer Agents: Molecular Design and their Synthesis
N Shankaraiah, Assistant Professor, NIPER, Hyderabad

Hall 2- Chemical Biology Approaches for Target Identification in "Activity Based Proteomic Profiling" Session
Maria Costi, Professor, University of Modena and Reggio Emilia

Technology Spotlight:
Hall 2: Using Protein Design Tools to Guide Pharmacophore Generation and Screening
Anand Krishnamurthy, Senior Scientist

Hall 1- Nanodrug Delivery in Reversing Multidrug Resistance in Cancer Cells
Mayur Yergeri, Professor & Prinicipal, Dr Bhanuben Nanavati College of Pharmacy

Technology Spotlight:
Hall 1: Drug Discovery & Development: The dilemma of Investing in Software Solutions
K K Bhagchandani, Director

Hall1: Lunch and Networing in the Exhibition Area

Hall 2- Rethinking Drug Discovery: Going-in for Signaling Pathways and Novel Chemical Space to Hunt for Next Generation Functional Small Molecules
Prabhat Arya, Professor and Head, Dr Reddy's Institute of Life Sciences

Hall 2: Lunch and Networking in the Exhibition Area

Hall 2- Drugs through Mimicking the Actions of Glycosaminoglycans - Anticoagulants, AntiEmphysema/COPD and Anti-Cancer Stem Cells
Umesh Desai, Professor, Virginia Commonwealth University

Hall 1: Dundee, Drug Discovery Unit: Novel Targets and Small Molecule Inhibitors
Ian Gilbert, Head of Chemistry, University of Dundee

Technology Spotlight:
Hall 2: Maximising Value and Success with Automation
Lesley Schultz, Product Manager

Hall 2-Special Lecture: Protein Ubiquitination Enzymes as Novel Cancer Therapeutic Targets
Amit Banerjee, Professor, Wayne State University

Hall 1: Coffee Break and Networking in Exhibition Area

Hall 1- Open-Source Chemoinformatics for virtual screening in Drug Discovery
Muthukumarasamy Karthikeyan, Principal Scientist, National Chemical Laboratory

Hall 2- Advances in Developing Tankyrase Selective Inhibitors
Stefan Krauss, Director, University Of Oslo

Hall 1- Pharmacophore Modeling and Molecular Docking Based Thriving Protocol for Target Identification
Vijay Masand, Assistant Professor, Vidya Bharti College

Hall 2- Molecular Methods that Enable Targeted Therapeutics and Precision Medicine
Manohar Furtado, Founder and President, Biology For Global Good Consulting Llc

End of First Day of Conference

FREE WORKSHOP: RNA Silencing in Drug Discovery- Challenges and Strategies

Hall 2- Plenary Talk: Bioprocessing of Human Pluripotent Stem Cells using CompacT SelecT Cell Culture Automation
Yacine Laabi, Research Group Leader, Institute for Stem Cell Therapy and Exploration of Monogenic Diseases

Hall 1- Special Lecture: Moving from Single Drug to Formulation Discovery
Bhushan Patwardhan, Professor & Director- ISHS, University of Pune

Hall 2- Stem Cell Based Chip Platforms In Drug Discovery
Subadra Dravida, Founder CEO, Tran-Scell Biologics Pvt. Ltd.

Hall 1- Natural Products for Drug Discovery and Development: Inspiration from the “Ancient Wisdom of Mother Nature"
Mukund Chorghade, President & CSO, Chorghade Enterprises

Technology Spotlight:
Hall 2: Fluent™ Laboratory Automation Solution for Cell-Based Assays
Roland Durner, Global Head of LSB Distributors

Hall 1:Coffee Break and Networking in Exhibition Area

Hall 2: Coffee Break and Networking in Exhibition Area

Hall 1- "NMITLI Arthritis Model" (Validating Ayurvedic Drugs for Global Use).
Arvind Chopra, Director and Chief Rheumatologist, Center for Rheumatic Diseases

Hall 2- Annotating Biological Activities Of Drugs, Natural Products, And Environmental Toxicants by FACTORIAL™ Pathway Profiling Assays
Sergei Makarov, Chief Executive Officer, Attagene Inc

Hall 1- Natural Products as New Sources of Drug and Nutraceutical Discovery
Lal Hingorani, Chairman/ Managing Director, Pharmanza Herbal Pvt. Ltd

Hall 2- Cell Based Assays in Clinical Diagnostics: Applications to Neutralizing Antibody Assays, Pharmacogenomics, and Personalized Medicine
John Watson, Director, Promega Corporation

Hall 1- Plenary Talk: High-throughput in vivo Vertebrate Screening: an Automation Point of View
Giancarlo Basile, Editor in Chief, Current Research in Drug Discovery

Hall 2- Optimisation of New Trypanosoma brucei Inhibitors
Raphael Rahmani, Research Fellow, Monash University

Hall 1- Discovery of Novel Compounds for the Treatment of Drug Resistant and Persistent Tuberculosis
Rajkumar Halder, Scientist E, Translational Health Science and Technology Institute

Hall 2- Repositioning of Drugs-Structure-Based Approach towards Finding New Leads as Antileishmanial Agents
Sanjay Batra, Principal Scientist, CSIR Central Drug Research Institute

Hall 1- High Content Image- Based Screening of a Protease Inhibitor Library Reveals Compounds Broadly Active against Multiple Highly Pathogenic RNA Viruses
Krishna Kota, Scientist, PerkinElmer

Hall 2- Special Lecture: Natural Products Repurposing for Cancer Therapy
Petr Bartunek, Group Leader, Academy of Sciences of the Czech Republic

Technology Spotlight:
Hall 1: Leveraging the Power of High Throughput Screening to Identify a Diastereomeric Salt for Chiral Resolution
David Yamane, Product Marketing Director

Hall 2: Lunch and Networking in Exhibition Area

Hall 1:Lunch and Networking in the Exhibition Area

POSTER EVALUATION

Accelerated and Reliable Lead Discovery: Structure Guided Drug Discovery Ideal for Collaborative Projects
Kal Ramnarayan, President and Chief Scientific Officer, Sapient Discovery

Opportunities for Strategic Research Partnerships in Drug Discovery
Ajith Kamath, Head, Pfizer Inc

Crowdsourcing Systems Level Platform for Open Source Drug Discovery
Anshu Bhardwaj, Scientist, CSIR- Open Drug Discovery Unit

Open Source Drug Discovery for Tuberculosis: Lessons to learn
Anamik Shah, Vice Chancellor, Gujarat Vidyapith

Open Discussion on Open Source Drug Discovery

Coffee Break and Networking in Exhibition Area

Panel Discussion: Drug Discovery- Contract Research Landscape in India 2020

End of the Conference